MARKETS PERPS LIVE42

Cash

Trending Elections Politics Sports Culture Crypto Commodities Climate Economics Mentions Finance Tech & Science

Predict Live42 AccountSocial

Product

Perpetual Futures Markets Incentive program Institutions API & developers

Company

About Kalshi Research Blog Careers Policy Center Brand Kit

Help

Help Center FAQ Fee schedule Trading hours Regulatory Trust Center

© 2026 Kalshi Inc. · All rights reserved

Privacy Data Terms of Service Trading Prohibitions FAQ for Finance Professionals

Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.

Trending Elections Politics Sports Culture Crypto Commodities Climate Economics Mentions Finance Tech & Science

Johnson & Johnson (JNJ) earnings | Kalshi

Johnson & Johnson

JNJ

ReportsJul 15, 2026 · time not confirmed

Fiscal periodNot stated

Market capNot available

Consensus EPSNot covered

Year-ago EPSNot available

Expected changeNot available

Quarterly markets

What will Johnson & Johnson say during their next earnings call?

Darzalex Faspro
100%
Rybrevant
100%
Procedure
100%
Administration
100%
Gene Therapy
100%
Nipocalimab / Lupus
100%
China
100%
Ottava
100%
Halda Therapeutics
100%
Europe
100%
Trufill
100%
Vaccine
100%

3 more words trade on this call